Global Anti-inflammatory Biologics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Anti-inflammatory Biologics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.
Anti-inflammatory Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-inflammatory Biologics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Arthritis and Respiratory Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-inflammatory Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-inflammatory Biologics key manufacturers include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sun Pharmaceutical Industries Ltd and Sanofi, etc. AbbVie, Johnson & Johnson, Amgen Inc are top 3 players and held % sales share in total in 2022.
Anti-inflammatory Biologics can be divided into Synthetic Type and Biological Type, etc. Synthetic Type is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-inflammatory Biologics is widely used in various fields, such as Arthritis, Respiratory Diseases, Dermatology and Gastroenterology, etc. Arthritis provides greatest supports to the Anti-inflammatory Biologics industry development. In 2022, global % sales of Anti-inflammatory Biologics went into Arthritis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-inflammatory Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline
Segment by Type
Synthetic Type
Biological Type
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-inflammatory Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-inflammatory Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-inflammatory Biologics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anti-inflammatory Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-inflammatory Biologics introduction, etc. Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anti-inflammatory Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Anti-inflammatory Biologics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-inflammatory Biologics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Arthritis and Respiratory Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-inflammatory Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-inflammatory Biologics key manufacturers include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sun Pharmaceutical Industries Ltd and Sanofi, etc. AbbVie, Johnson & Johnson, Amgen Inc are top 3 players and held % sales share in total in 2022.
Anti-inflammatory Biologics can be divided into Synthetic Type and Biological Type, etc. Synthetic Type is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-inflammatory Biologics is widely used in various fields, such as Arthritis, Respiratory Diseases, Dermatology and Gastroenterology, etc. Arthritis provides greatest supports to the Anti-inflammatory Biologics industry development. In 2022, global % sales of Anti-inflammatory Biologics went into Arthritis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-inflammatory Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline
Segment by Type
Synthetic Type
Biological Type
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-inflammatory Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-inflammatory Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-inflammatory Biologics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anti-inflammatory Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-inflammatory Biologics introduction, etc. Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anti-inflammatory Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices